Medaora is a pharmaceutical distributor and service provider focused on the commercialization of medicines. Our capabilities include marketing and sales, compliance, pharmacovigilance, quality assurance, regulatory and medical affairs as well as market access.
We are passionate about healthcare.
We’ve started companies and worked in business, scientific, technical, medical, and investment environments. The result is an unsurpassed level of industry understanding and knowledge that informs every project.
Commercial platform with physical presence in the UK, EU, Middle East and Eurasia supporting patients with delivery and distribution of unlicensed medicines.
Highly-skilled teams of PhDs, MBAs, industry experts and our relationship with renowned CROs & CDMOs, brings us robust strategy and value creation capabilities to guide investment priorities and translate innovation into commercial value.
We identify the best internal and external opportunities to gain commercial advantage in growing cross-sector areas such as precision medicine, drug delivery, and digital therapeutics.
We deliver innovative strategies and solutions to maximize the ROI, refine commercialization processes, and streamline operations, boosting growth and competitive advantage.
Established/Mature brands require a certain degree of market awareness. As these brands’ revenue profiles continue to deteriorate over years, we focus on each asset's ultimate sales and market performance goals to maximize product value before its loss of exclusivity, and optimize revenue at the late stages of the product life cycle.
As manufacturers look at different investment models while becoming pure-players, these variables and others that could potentially impact their brand must be considered to make the best discretionary choices for maintaining to versus divesting costs. The solutions will be different for every brand, which is why.
Monitor the competitive landscape, validate investments and strategically prioritize your portfolio so you can focus on maximizing ROI and improving patient outcomes. Enhance your forecasts and gain competitive via identifying new competitor programs sooner, or find and invest in assets before your competitors do.
Inform decisions using expansive coverage of clinical, deals, regulatory and patent intel tied to each drug and company, sourced from global conferences and industry news.
Craft tailor made comprehensive plans to identify target markets, assess market potential and overcome access barriers, enabling successful product launches. access turnaround and late-stage recovery
Manufacturers and suppliers of medicines must comply with price control mechanisms, by participating pharmaceutical contribution schemes. In response to the prominent challenges, maintain your competitive edge without having major adjustments on the growth.
Trusted partner for the supply of generics, branded medicines and pharmaceutical services.
Providing services compliant with some of the most stringent regulations in the world to ensure
the best quality pharmaceutical medicines are supplied.
Exclusive distributor of Noumed in emerging markets and reduced wholesaler in expanded regions.
Through our network of partners and vast network of suppliers across the EU, we provide one of the largest PLPI licenses.
Sometimes referred as: Compassionate Use, Expanded Access, Managed Access or Early Access Programmes.
Building enduring commercial partnerships is fundamental to our long term business development and growth strategies. Our partners include manufacturers, logistics firms & distributors who all share the same aim to increase global access to high quality, life-saving and life-enhancing medicines whilst working in-line with industry best practice.
As a company that values innovation and collaboration, we are always looking for opportunities to partner with other organizations that share our vision and mission. If you are interested in exploring potential synergies with us, please reach our Business Development department using contact form.
Our partners are carefully selected and must undergo our internal due diligence & compliance checks as well as on-site audits to ensure that they meet the quality and compliance standards required to operate within our heavily regulated and global industry.
.svg)
.svg)
Unable to commercialise alone due to lack of footprint, resources and regional knowledge in a particular territory? Get in touch with us to not to experience unexpected disruption in the supply chain or decide to withdraw from a market or markets.
Our clients and their patients benefit from our product/brand managers based ‘in region’ and global network of approved and audited suppliers to help us access hard-to-reach markets.
Explore our comprehensive commercial services, from early-stage development to commercialisation, all under one roof, eliminating the need for subcontracting.
Develop a go-to-market and partnering strategy that leverages your strengths while gaining external synergies, anticipate leakage points in the patient journey and develop strategies to maximize adoption.
